Treating Nodular Lymphocyte Predominant Hodgkin Disease (NLPHD)
Because this rare type of Hodgkin disease (HD) tends to grow more slowly than classic HD, it is sometimes treated slightly differently.
If the disease is more advanced or if a person has B symptoms, chemotherapy, with or without radiation therapy, is likely to be recommended. Many doctors use the ABVD chemo regimen, although some doctors prefer others. Another option is to give the monoclonal antibody rituximab (Rituxan), with or without chemotherapy (and sometimes radiation).
An option for some people who are not having major symptoms might be to have the disease watched closely at first, and then start treatment only when symptoms appear.
Last Medical Review: July 10, 2014 Last Revised: May 23, 2016
- Chemotherapy for Hodgkin Disease
- Radiation Therapy for Hodgkin Disease
- Immunotherapy for Hodgkin Disease
- High-dose Chemotherapy and Stem Cell Transplant for Hodgkin Disease
- Treating Classic Hodgkin Disease, by Stage
- Treating Nodular Lymphocyte Predominant Hodgkin Disease (NLPHD)
- Treating Hodgkin Disease in Children
- Hodgkin Disease in Pregnancy